CAFTA Could Hurt Generic Drug Exports To Central America, GPhA Says

The Dominican Republic-Central American Free Trade Agreement threatens the generic drug industry because it lacks Waxman-Hatch-type access provisions to balance intellectual property protections, the Generic Pharmaceutical Association says